Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Cell Reports Medicine - Tập 3 - Trang 100685 - 2022
Leonie M. Weskamm1,2,3, Anahita Fathi1,2,3,4, Matthijs P. Raadsen5, Anna Z. Mykytyn5, Till Koch1,2,3,4, Michael Spohn6,7,8, Monika Friedrich1,2,3, Bart L. Haagmans5, Stephan Becker9,10, Gerd Sutter11,12
1Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
2Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
3German Centre for Infection Research, Hamburg-Lübeck-Borstel-Riems, Germany
4First Department of Medicine, Division of Infectious Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
5Department of Virology, Erasmus Medical Centre, Rotterdam, the Netherlands
6Research Institute Children’s Cancer Centre Hamburg, Hamburg, Germany
7Department of Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
8Bioinformatics Core Unit, Hamburg University Medical Centre, Hamburg, Germany
9German Centre for Infection Research, Gießen-Marburg-Langen, Germany
10Institute for Virology, Philipps University Marburg, Marburg, Germany
11German Centre for Infection Research, München, Germany
12Division of Virology, Institute for Infectious Diseases and Zoonoses, Department of Veterinary Sciences, LMU Munich, Munich, Germany

Tài liệu tham khảo

2021

Modjarrad, 2016, A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation, Nat. Med., 22, 701, 10.1038/nm.4131

Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721

Gossner, 2016, Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection, Zoonoses Public Health, 63, 1, 10.1111/zph.12171

Hui, 2018, Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission, Lancet Infect. Dis., 18, e217, 10.1016/S1473-3099(18)30127-0

Cauchemez, 2014, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect. Dis., 14, 50, 10.1016/S1473-3099(13)70304-9

Cauchemez, 2016, Unraveling the drivers of MERS-CoV transmission, Proc. Natl. Acad. Sci. USA, 113, 9081, 10.1073/pnas.1519235113

West, 1996, Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination, Vaccine, 14, 1019, 10.1016/0264-410X(96)00062-X

Bauer, 2006, Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination, Vaccine, 24, 572, 10.1016/j.vaccine.2005.08.058

Yong, 2019, Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus, Front. Microbiol., 10, 1781, 10.3389/fmicb.2019.01781

Park, 2019, Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex, BMB Rep., 52, 397, 10.5483/BMBRep.2019.52.6.185

Li, 2016, Structure, function, and evolution of coronavirus spike proteins, Annu. Rev. Virol., 3, 237, 10.1146/annurev-virology-110615-042301

Lu, 2014, Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor, Nat. Commun., 5, 3067, 10.1038/ncomms4067

Zhang, 2014, Current advancements and potential strategies in the development of MERS-CoV vaccines, Expert Rev. Vaccines, 13, 761, 10.1586/14760584.2014.912134

Koch, 2020, Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial, Lancet Infect. Dis., 20, 827, 10.1016/S1473-3099(20)30248-6

Folegatti, 2020, Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial, Lancet Infect. Dis., 20, 816, 10.1016/S1473-3099(20)30160-2

Modjarrad, 2019, Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial, Lancet Infect. Dis., 19, 1013, 10.1016/S1473-3099(19)30266-X

Bosaeed, 2022, Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial, Lancet Microbe., 3, e11, 10.1016/S2666-5247(21)00193-2

Song, 2013, Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies, J. Virol., 87, 11950, 10.1128/JVI.01672-13

Fathi, 2022, Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome, medRxiv

Sanz, 2019, Challenges and opportunities for consistent classification of human B cell and plasma cell populations, Front. Immunol., 10, 2458, 10.3389/fimmu.2019.02458

Slifka, 1998, Humoral immunity due to long-lived plasma cells, Immunity, 8, 363, 10.1016/S1074-7613(00)80541-5

Palgen, 2020, Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations, NPJ Vaccines, 5, 24, 10.1038/s41541-020-0175-8

Sallusto, 2010, From vaccines to memory and back, Immunity, 33, 451, 10.1016/j.immuni.2010.10.008

Voysey, 2021, Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, Lancet, 397, 881, 10.1016/S0140-6736(21)00432-3

Voysey, 2021, ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - authors' reply, Lancet, 397, 2248, 10.1016/S0140-6736(21)00976-4

Pitisuttithum, 2020, Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial, Lancet HIV, 7, e238, 10.1016/S2352-3018(19)30406-0

Kreijtz, 2014, Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial, Lancet Infect. Dis., 14, 1196, 10.1016/S1473-3099(14)70963-6

de Vries, 2018, Induction of cross-clade antibody and T-cell responses by a modified vaccinia virus ankara-based influenza A(H5N1) vaccine in a randomized phase 1/2a clinical trial, J. Infect. Dis., 218, 614, 10.1093/infdis/jiy214

Munro, 2021, Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial, Lancet, 398, 2258, 10.1016/S0140-6736(21)02717-3

Wang, 2021, A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies, Nat. Commun., 12, 1715, 10.1038/s41467-021-21968-w

Nguyen-Contant, 2020, S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit, mBio, 11, 10.1128/mBio.01991-20

Zohar, 2020, Compromised humoral functional evolution tracks with SARS-CoV-2 mortality, Cell, 183, 1508, 10.1016/j.cell.2020.10.052

Fischinger, 2020, IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees, JCI Insight, 5, 140925, 10.1172/jci.insight.140925

Arnold, 2018, Prospects from systems serology research, Immunology, 153, 279, 10.1111/imm.12861

Rowntree, 2021, Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features, Clin. Transl. Immunol., 10, e1258, 10.1002/cti2.1258

Selva, 2021, Systems serology detects functionally distinct coronavirus antibody features in children and elderly, Nat. Commun., 12, 2037, 10.1038/s41467-021-22236-7

Boudreau, 2019, Extra-neutralizing FcR-mediated antibody functions for a universal influenza vaccine, Front. Immunol., 10, 440, 10.3389/fimmu.2019.00440

Barrett, 2021, Author Correction: phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses, Nat. Med., 27, 1113, 10.1038/s41591-021-01372-z

Damelang, 2019, Role of IgG3 in infectious diseases, Trends Immunol., 40, 197, 10.1016/j.it.2019.01.005

Chung, 2014, Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines, Sci. Transl. Med., 6, 228ra38, 10.1126/scitranslmed.3007736

Khoury, 2021, Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, Nat. Med., 27, 1205, 10.1038/s41591-021-01377-8

Earle, 2021, Evidence for antibody as a protective correlate for COVID-19 vaccines, Vaccine, 39, 4423, 10.1016/j.vaccine.2021.05.063

Moss, 2022, The T cell immune response against SARS-CoV-2, Nat. Immunol., 23, 186, 10.1038/s41590-021-01122-w

Kim, 2021, Sustained responses of neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV) in recovered patients and their therapeutic applicability, Clin. Infect. Dis., 73, e550, 10.1093/cid/ciaa1345

Plotkin, 2014, History of vaccination, Proc. Natl. Acad. Sci. USA, 111, 12283, 10.1073/pnas.1400472111

Tay, 2022, Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection, EMBO Mol. Med., 14, e15227, 10.15252/emmm.202115227

Cheon, 2022, Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study, Clin. Microbiol. Infect., 28, 292, 10.1016/j.cmi.2021.06.009

Alshukairi, 2016, Antibody Response and Disease Severity in Healthcare Worker MERS Survivors, Emerg Infect Dis, 22, 1113, 10.3201/eid2206.160010

Brown, 2012, High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples, J. Immunol. Methods, 386, 117, 10.1016/j.jim.2012.09.007

Thông tin
Thông tin xuất bản

Cell Reports Medicine

Tập 3

100685

Thông tin tác giả